Association between diabetes mellitus and fatty liver based on ultrasonography screening in the world's highest cholangiocarcinoma incidence region, Northeast Thailand

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 9, 2015, Pages 3931-3936

  Thinkhamrop, Kavin ^a   Khuntikeo, Narong ^a   Phonjitt, Pichai ^a   Chamadol, Nittaya ^a   Thinkhamrop, Bandit ^a   Moore, Malcolm Anthony ^a   Promthet, Supannee ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Diabetes mellitus; Fatty liver; Screening; Thailand; Ultrasonography

Indexed keywords

ADULT; BILE DUCT CARCINOMA; BILE DUCT TUMOR; CANCER STAGING; COMPLICATION; DIABETES MELLITUS; ECHOGRAPHY; FATTY LIVER; FEMALE; FOLLOW UP; HUMAN; INTRAHEPATIC BILE DUCT; MALE; MASS SCREENING; MIDDLE AGED; ODDS RATIO; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; RISK FACTOR; THAILAND;

ADULT; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; DIABETES MELLITUS; FATTY LIVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; ODDS RATIO; PREVALENCE; PROGNOSIS; RISK FACTORS; THAILAND;

EID: 84930166946     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.9.3931     Document Type: Article

References (33)

1. Adami HO, Chow WH, Nyren O, et al (1996). Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst, 88, 1472-7.
2. Aekplakorn W, Stolk RP, Neal B, et al (2003). The prevalence and management of diabetes in Thai adults: the international collaborative study of cardiovascular disease in Asia. Diabetes Care, 26, 2758-63.
3. Browning JD, Szczepaniak LS, Dobbins R, et al (2004). Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatol, 40, 1387-95.
4. Cheung O, Sanyal AJ (2008). Hepatitis C infection and nonalcoholic fatty liver disease. Clin Liver Dis, 12, 573-85.
5. Deerochanawong C, Ferrario A (2013). Diabetes management in Thailand: a literature review of the burden, costs, and outcomes. Global Health, 9, 11.
6. Eguchi Y, Hyogo H, Ono M, et al (2012). Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. J Gastroenterol, 47, 586-95.
7. Fan JG (2007). [An introduction of strategies for the management of nonalcoholic fatty liver disease (NAFLD) recommended by Asia Pacific Working Party on NAFLD]. Zhonghua Gan Zang Bing Za Zhi, 15, 552-3.
8. Fan JG, Zhu J, Li XJ, et al (2005). Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol, 43, 508-14.
9. Foster T, Anania FA, Li D, et al (2013). The prevalence and clinical correlates of nonalcoholic fatty liver disease (NAFLD) in African Americans: the multiethnic study of atherosclerosis (MESA). Dig Dis Sci, 58, 2392-8.
10. Fung J, Lee CK, Chan M, et al (2014). High prevalence of nonalcoholic fatty liver disease in the Chinese-results from the Hong Kong liver health census. Liver Int. (in press).
11. Hsing AW, Zhang M, Rashid A, et al (2008). Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China. Int J Cancer, 122, 1849-53.
12. Hu X, Huang Y, Bao Z, et al (2012). Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units. BMC Gastroenterol, 12, 123.
13. Jeong EH, Jun DW, Cho YK, et al (2013). Regional prevalence of non-alcoholic fatty liver disease in Seoul and Gyeonggido, Korea. Clin Mol Hepatol, 19, 266-72.
14. Jing W, Jin G, Zhou X, et al (2012). Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis. Eur J Cancer Prev, 21, 24-31.
15. Kim SH, Lee JW, Hwang HJ (2011). Associations between combinations of body mass index plus non-alcoholic fatty liver disease and diabetes mellitus among Korean adults. Asia Pac J Clin Nutr, 20, 14-20.
16. Leite NC, Salles GF, Araujo AL, et al (2009). Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus. Liver Int, 29, 113-9.
17. Loomba R, Sanyal AJ (2013). The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol, 10, 686-90.
18. Mohammad-Alizadeh AH, Ghobakhlou M, Shalmani HM, et al (2012). Cholangiocarcinoma: an-eight-year experience in a tertiary-center in Iran. Asian Pac J Cancer Prev, 13, 5381-4.
19. O'Shea RS, Dasarathy S, McCullough AJ, et al (2010). Alcoholic liver disease. Hepatol, 51, 307-28.
20. Palmer WC, Patel T (2012). Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol, 57, 69-76.
21. Shaib YH, El-Serag HB, Davila JA, et al (2005). Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterol, 128, 620-6.
22. Shaw JE, Sicree RA, Zimmet PZ (2010). Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract, 87, 4-14.
23. Shebl FM, Andreotti G, Meyer TE, et al (2011). Metabolic syndrome and insulin resistance in relation to biliary tract cancer and stone risks: a population-based study in Shanghai, China. Br J Cancer, 105, 1424-9.
24. Shi L, Liu ZW, Li Y, et al (2012). The prevalence of nonalcoholic fatty liver disease and its association with lifestyle/dietary habits among university faculty and staff in Chengdu. Biomed Environ Sci, 25, 383-91.
25. Silva IdS (1999). Cancer Epidemiology: Principles and Methods. IARC Press.
26. Stata Corp LP (2007). Stata Release 10: User's guide. College Station TX: Stata Press.
27. Suomela E, Oikonen M, Virtanen J, et al (2014). Prevalence and determinants of fatty liver in normal-weight and overweight young adults. The Cardiovascular Risk in Young Finns Study. Ann Med, 1-7.
28. Welzel TM, Graubard BI, El-Serag HB, et al (2007a). Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol, 5, 1221-8.
29. Welzel TM, Mellemkjaer L, Gloria G, et al (2007b). Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: A nationwide case-control study. Int J Cancer, 120, 638-41.
30. Wong VW, Wong GL, Chu WC, et al (2012). Hepatitis B virus infection and fatty liver in the general population. J Hepatol, 56, 533-40.
31. Wu Y, Ahmed A, Kamal A (2013). Donor diabetes mellitus is an independent risk factor for graft loss in HCV positive but not HCV negative liver transplant recipients. Dig Dis Sci, 58, 574-8.
32. Xiao SJ, Fu GJ, Lv YL, et al (2014). Prevalence and risk factors of fatty liver disease in young and middle-aged population: one center study in Southwestern China. J Gastroenterol Hepatol, 29, 358-64.
33. Yan Y, Bian H, Xia MF, et al (2013). Liver disease spectrum in hospitalized type 2 diabetes and related risk factors analysis of non-alcoholic fatty liver disease. Zhonghua Yi Xue Za Zhi, 93, 270-4 (in Chinese).